Pages that link to "Q35906093"
Jump to navigation
Jump to search
The following pages link to Gene therapy for autoimmune diseases: quo vadis? (Q35906093):
Displaying 15 items.
- Gene therapy for arthritis--where do we stand? (Q24812824) (← links)
- Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord (Q36013050) (← links)
- Gene therapeutics in Sjögren's syndrome (Q36161211) (← links)
- Application of cellular gene therapy for rheumatoid arthritis (Q36622653) (← links)
- Engineering stem cells for therapy (Q36804669) (← links)
- The promising alliance of anti-cancer electrochemotherapy with immunotherapy (Q37014373) (← links)
- Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis (Q37051562) (← links)
- Overexpression of thioredoxin in islets transduced by a lentiviral vector prolongs graft survival in autoimmune diabetic NOD mice (Q37329066) (← links)
- HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery (Q39084265) (← links)
- Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery (Q39405505) (← links)
- T-cell receptor- and anti-inflammatory gene-modulated T cells as therapy for autoimmune disease (Q40159251) (← links)
- A remote and highly conserved enhancer supports amygdala specific expression of the gene encoding the anxiogenic neuropeptide substance-P. (Q40359293) (← links)
- Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells (Q40371833) (← links)
- Targeted gene therapy of autoimmune diseases: advances and prospects (Q45859107) (← links)
- Cationic nanomicelles for delivery of plasmids encoding interleukin-4 and interleukin-10 for prevention of autoimmune diabetes in mice (Q82468690) (← links)